Drug recall · March 23, 2022
hydrALAZINE HCl Tablets recall
Why: Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61
- Lots / codes
Lot #: T03755, T03756, Exp. Date 03/2023
- Quantity
- 5,953 cartons
- Company
- The Harvard Drug Group, Livonia, MI
- Distribution
- Nationwide within USA
- Initiated
- February 24, 2022 · Voluntary: Firm initiated
- Classified
- March 14, 2022
- Reported
- March 23, 2022
- Ended
- July 16, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydralazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.